Shintaro Mori
Overview
Explore the profile of Shintaro Mori including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mori S, Shimizu T, Hisakado M, Nakayama K
Phys Rev E
. 2025 Feb;
110(6-1):064122.
PMID: 39916256
Ant colony optimization leverages the parameter α to modulate the decision function's sensitivity to pheromone levels, balancing the exploration of diverse solutions with the exploitation of promising areas. Identifying the...
2.
Honda H, Matsuo T, Mori S, Araki K, Mitsunari K, Ohba K, et al.
Hinyokika Kiyo
. 2024 Dec;
70(11):361-366.
PMID: 39710840
In 2021, Enfortumab Vedotin (EV) was approved for the treatment of locally advanced and metastatic urothelial carcinoma (UC) in Japan. Some patients require withdrawal or dose reduction due to cutaneous...
3.
Matsuo T, Kakita S, Honda H, Mori S, Araki K, Mitsunari K, et al.
Medicina (Kaunas)
. 2024 Nov;
60(11).
PMID: 39597014
: This study aimed to investigate the relationship between lower urinary tract symptoms (LUTS) and tooth loss due to chronic periodontitis. : A total of 232 patients aged 40 years...
4.
Mori S, Matsuo T, Honda H, Araki K, Mitsunari K, Ohba K, et al.
IJU Case Rep
. 2024 Jul;
7(4):324-328.
PMID: 38966765
Introduction: Few studies have reported on administering enfortumab vedotin to patients with metastatic urothelial carcinoma and end-stage renal disease requiring hemodialysis. Case Presentation: Case 1: An 85-year-old man underwent hemodialysis...
5.
Mori S, Matsuo T, Honda H, Araki K, Mitsunari K, Ohba K, et al.
In Vivo
. 2024 Jun;
38(4):2031-2040.
PMID: 38936892
Background/aim: Overactive bladder (OAB) has recently been recognized as an independent risk factor for falls and fractures. This study aimed to predict fracture risk in female patients with OAB symptoms....
6.
Hisakado M, Hattori K, Mori S
Phys Rev E
. 2022 Oct;
106(3-1):034106.
PMID: 36266900
This paper considers a multiterm urn process that has a correlation in the same term and temporal correlation. .The objective is to clarify the relationship between the urn model and...
7.
Nakayama K, Mori S
Phys Rev E
. 2021 Aug;
104(1-1):014109.
PMID: 34412319
We study the phase transition and the critical properties of a nonlinear Pólya urn, which is a simple binary stochastic process X(t)∈{0,1},t=1,⋯, with a feedback mechanism. Let f be a...
8.
Kanenawa K, Isotani A, Yamaji K, Nakamura M, Tanaka Y, Hirose-Inui K, et al.
ESC Heart Fail
. 2021 Feb;
8(2):1552-1561.
PMID: 33547759
Aims: There is currently no gold standard in evaluating frailty in patients with heart failure (HF), and the prognostic value of frailty according to the Canadian Study of Health and...
9.
Tadano K, Okamoto Y, Isobe T, Mori S, Suzuki H, Minami M, et al.
Magn Reson Imaging
. 2020 Aug;
73:70-75.
PMID: 32853758
Introduction: Several studies investigated the changes in diffusion of water molecules in skeletal muscle cells of lifestyle-related-disease patients who performed a hybrid training (HYBT) for six months. They reported that...
10.
Mori S, Isotani A, Yamaji K, Yano M, Morinaga T, Hayashi M, et al.
JACC Cardiovasc Interv
. 2019 Dec;
13(5):653-654.
PMID: 31786217
No abstract available.